ANIX - Anixa Biosciences Inc

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 3.17

Open

$ 3.27

Bid

$ 3.15 x 100

Ask

-- x --

Day's Range

$ 3.16 - $ 3.27

52 Week Range

$ 2.15 - $ 5.13

Volume

42,261

Average Volume

Market Cap

102.01M

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	09-06-2024	07-31-2024	10-Q
2	06-04-2024	04-30-2024	10-Q
3	03-12-2024	01-31-2024	10-Q
4	01-16-2024	10-31-2023	10-K
5	09-06-2023	07-31-2023	10-Q
6	06-14-2023	04-30-2023	10-Q
7	03-17-2023	01-31-2023	10-Q
8	01-04-2023	10-31-2022	10-K
9	09-09-2022	07-31-2022	10-Q
10	06-10-2022	04-30-2022	10-Q
11	03-11-2022	01-31-2022	10-Q
12	01-04-2022	10-31-2021	10-K
13	09-01-2021	07-31-2021	10-Q
14	06-10-2021	04-30-2021	10-Q
15	03-11-2021	01-31-2021	10-Q
16	01-07-2021	10-31-2020	10-K
17	09-08-2020	07-31-2020	10-Q
18	06-09-2020	04-30-2020	10-Q
19	03-09-2020	01-31-2020	10-Q
20	01-09-2020	10-31-2019	10-K
21	09-06-2019	07-31-2019	10-Q
22	06-12-2019	04-30-2019	10-Q
23	03-13-2019	01-31-2019	10-Q
24	01-11-2019	10-31-2018	10-K
25	09-07-2018	07-31-2018	10-Q
26	06-11-2018	04-30-2018	10-Q
27	03-09-2018	12-01-2017	10-Q
28	01-09-2018	10-31-2017	10-K
29	09-08-2017	07-31-2017	10-Q
30	05-26-2017	04-30-2017	10-Q
31	03-16-2017	01-31-2017	10-Q
32	12-07-2016	10-31-2016	10-K
33	08-19-2016	07-31-2016	10-Q
34	05-20-2016	04-30-2016	10-Q
35	02-19-2016	01-31-2016	10-Q
36	12-23-2015	10-31-2015	10-K
37	08-18-2015	07-31-2015	10-Q
38	05-22-2015	04-30-2015	10-Q
39	03-09-2015	01-31-2015	10-Q
40	01-29-2015	10-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

EF Hutton Maintains Buy on Anixa Bioscienc...
09/09/2024 15:54:23

EF Hutton analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.

Anixa Biosciences Presents Ovarian Cancer ...
09/03/2024 12:34:57

EF Hutton Initiates Coverage On Anixa Bios...
08/07/2024 11:18:31

EF Hutton analyst Jason Kolbert initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price ...

Anixa Biosciences To Presentation Its Ovar...
07/29/2024 12:48:51

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

anixa-biosciences-and-3-other-stocks-under-5-insiders-are-buying

Anixa Biosciences And 3 Other Stocks Under...
07/29/2024 11:13:50

HC Wainwright & Co. Reiterates Buy on Anix...
07/24/2024 10:20:26

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $7 price target.

Anixa Biosciences Collaborator, Cleveland ...
07/17/2024 12:07:49

Anixa Biosciences Treats Sixth Patient In ...
06/24/2024 12:46:21

HC Wainwright & Co. Maintains Buy on Anixa...
06/10/2024 10:42:52

HC Wainwright & Co. analyst Yi Chen maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and lowers the price target fro...

Anixa Biosciences Begins Treatment Of Fift...
05/21/2024 11:33:51

Anixa Biosciences Partners With Cleveland ...
05/08/2024 12:27:48

Anixa Biosciences 13D Filing Shows Preside...
05/03/2024 17:34:09

- SEC Filing

HC Wainwright & Co. Reiterates Buy on Anix...
03/21/2024 10:33:41

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

Recap: Anixa Biosciences Q1 Earnings
03/12/2024 21:45:06

HC Wainwright & Co. Reiterates Buy on Anix...
02/13/2024 17:28:22

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

Anixa Biosciences Initiates Dosing in Seco...
02/12/2024 12:33:39

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a clinical-stage biotechnology company focus...

Anixa Biosciences Announces Japanese Paten...
01/23/2024 13:06:35

Broad coverage extended to Japan and related regionsSAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. (&#...

anixa-biosciences-reveals-updated-data-from-breast-cancer-vaccine-trial-says-exceeded-expectations

Anixa Biosciences Reveals Updated Data Fro...
12/07/2023 14:58:22

Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
12/07/2023 13:07:04

HC Wainwright & Co. Reiterates Buy on Anix...
12/07/2023 11:28:07

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.